Source: United States of America – Federal Government Departments (video statements)
Please join U.S. Department of Health and Human Services Secretary Xavier Becerra and Centers for Medicare & Medicaid Services Deputy Administrator and Center for Medicare Director Dr. Seshamani for a virtual roundtable discussion featuring Medicare enrollees from across the United States as they discuss the impact of the Biden-Harris Administration’s lower drug cost law, the Inflation Reduction Act. Through this law, President Biden and Vice President Harris are delivering lower costs for Americans with Medicare, including a $35 monthly cap for each covered insulin product and recommended vaccines for free like shingles, RSV, and Tdap. In 2024, some people with Medicare prescription drug coverage (Part D) who have high drug costs now have their out-of-pocket drug costs capped at about $3,500. Come January 2025, this benefit gets even better when everyone with Part D will have their out-of-pocket costs capped at $2,000. Finally, Medicare is now negotiating directly with participating drug companies to get lower prices for certain drugs.
—
U.S. Department of Health and Human Services (HHS) | http://www.hhs.gov | HHS Privacy Policy | http://www.hhs.gov/Privacy.html